Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy
Clinical trial NCT06510361 · RECRUITING
Trial details
- NCT number
- NCT06510361
- Sponsor
- Beth Israel Deaconess Medical Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-20
- Primary completion
- 2026-05-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.